Two new screenings and one powerful supplement can help
Pancreatic cancer is relatively rare—compared to breast or colon cancer.
But it’s particularly brutal… and downright deadly.
In fact, it has one of the LOWEST five-year survival rates of ALL cancers—at just under 10 percent.
Of course, this grim survival rate stems from the fact that we don’t usually discover it until the later stages, when the tumor has already advanced to organs beyond the pancreas, limiting your treatment options.
However, there are two new screenings on the horizon that promise to catch pancreatic cancer MUCH earlier… when it’s still “curable” with surgery!
Plus, taking a powerful supplement—that I routinely recommend—can SLASH your risk of developing this devastating cancer in the first place by more than 40 percent!
Let’s dive right into this important, life-saving research…
Stool-based screening shows promise
The first potential screen for pancreatic cancer involves a simple stool sample analysis.
(This means people could one day take it discretely at home and mail it into a lab for results—just as they do with Cologuard®, the non-invasive stool test for colon cancer.)
Then, using sophisticated computer analysis, the lab looks for 27 signature microbes (bacteria) that indicate the presence of pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer.
In early studies, this test looked to be about 84 percent accurate. Then, when an additional marker called carbohydrate antigen (CA) 19-9 was screened for, the accuracy jumped to about 94 percent!
Experts believe this stool-based screening will help diagnose pancreatic cancer at an earlier stage, when it’s still highly “curable” with surgery. It may even identify people at “high risk” for developing it. And that’s great news!
Unfortunately, there’s no definitive timeline for when it will hit the market. But a patent on the diagnostic kit is pending in the U.S., so it can’t be too far off. In any case, I’ll make sure to keep you posted.
Now, let’s move on to the second new screening option on the horizon…
Blood test detects pancreatic cancer—and MORE
A new blood-based test also shows a lot of potential for detecting pancreatic cancer… and SIX other cancers, as well.
Of course, we already use a few cancer blood tests—often called “liquid biopsies”—here in the U.S. They typically look for mutations within a cell.
But this new cancer blood test—called DELFI (DNA evaluation of fragments for early interception)—looks for strange fragments of DNA floating in the blood.
You see, when cancer cells die, they haphazardly release their DNA into the bloodstream. The new DELFI test uses complex computer analysis to detect these strange patterns. (Healthy, cancer-free patients don’t have these fragments floating in their blood.)
In addition, the DELFI test can reveal the source of the cancer in the body… and whether it started in the pancreas or one of six other spots—including the breast, colon, or lung.
And it’s pretty darn accurate too.
In fact, in initial testing, researchers with the Johns Hopkins School of Medicine accurately detected the presence of cancer DNA in up to 99 percent of blood samples taken from 208 patients.
Perhaps best of all…
The blood test detected cancer at an early enough stage when doctors could still surgically remove it… and essentially “cure” it.
Of course, just like the stool screening test for pancreatic cancer, we don’t know when this blood test will enter the market. Though, it does seem to be a little further along in the process—with a clinical trial involving 15,000 men and women already in the works.
In the meantime, until these two tests become mainstream, it’s critical that you know about the early warning signs of pancreatic cancer…
Watch out for TWO early warning signs
The U.K.’s National Cancer Research Institute recently looked at symptoms in nearly 25,000 men and women diagnosed with deadly pancreatic cancer.
And they noticed something quite remarkable…
There were two EARLY symptoms of pancreatic cancer that they’d never identified before:
- Dark urine
- Increased thirst
In fact, the patients with both pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, and pancreatic neuroendocrine neoplasms (PNEN), a rarer form, reported having these two symptoms up to ONE YEAR BEFORE receiving their cancer diagnosis.
And that’s key—because, again, it likely means these particular symptoms present much earlier, when the cancer hasn’t yet metastasized (spread) to other organs.
The researchers noted that PDAC and PNEN had other shared symptoms, including:
- Yellowing of the skin
- Changes in bowel habits
- Abdominal mass
- Abdominal pain
- Weight loss
While these symptoms aren’t just specific to pancreatic cancer, knowing them can help you recognize when something isn’t right with your body. It can also help primary care doctors decide whether or not to order further tests.
Which brings me to another important point…
There is one blood test—which you can (and SHOULD) get IMMEDIATELY—to avoid becoming a victim of this much-feared cancer…
The one blood test you should get RIGHT NOW
As I’ve frequently shared over the years, vitamin D (which is actually a hormone) protects you against any number of deadly diseases. And it TOPS my list of essential supplements I would want with me on a desert island.
Plus, new, exciting research shows it can help ward off pancreatic cancer!
In fact, in a recent meta-analysis, researchers looked at vitamin D intake on pancreatic cancer risk in nearly 125,000 men and women over 16 years.
During that time, the participants answered questions about their diet and supplement use. Ultimately, about 350 of them developed pancreatic cancer.
But there was a HUGE difference in risk between those who had the highest daily intake of vitamin D (equal to or more than 15 mcg [600 IU]) and those who had the lowest daily intake (less than 3.75 mcg [150 IU]).
In fact, those with the highest intake had a 40 percent LOWER risk of ever developing pancreatic cancer compared to those with the lowest!
According to Dr. Charles S. Fuchs, the study’s co-author and a medical oncologist with Dana-Farber Cancer institute in Boston, “We really have been struggling to find effective measure of prevention, so we are very excited by this effort.”
I’m excited, too. But for different reasons…
For one, this research finally highlights the importance of testing your vitamin D blood levels regularly. And it shows how taking steps to improve low levels can provide MAJOR protection against this deadly cancer.
As always, I recommend having your blood levels checked every six months. Just ask for the 25-hydroxyvitamin D
or 25(OH)D test. Your results should fall between 80 and 100 ng/mL.
But if you’re like the vast majority of people, your results will probably be much lower than that. So, you’ll need to supplement with at least 125 mcg (5,000 IU) of vitamin D3 per day to hit your target—and obtain the protective benefits for pancreatic cancer.
(Note, even this modest amount is much higher than the dosage used in the new research. Meaning you might gain even more protection from an optimal dose!)
If your levels are deficient (below 30 ng/mL), or if repeat testing shows your levels aren’t budging, I suggest increasing your dose to 250 mcg (10,000 IU) per day. That’s the amount I personally take daily… and so do many of my patients. It’s perfectly safe with regular monitoring.
So, there you have it—some very promising strategies for not only spotting the EARLY signs of pancreatic cancer… but for PREVENTING its development in the first place! All it takes is an easy addition to your supplement regimen, knowing which tests to ask for at your doctor’s office, and speaking up if something seems “off” with your body.
And, as promised, I’ll keep you up to date about the new stool and DELFI blood tests for pancreatic cancer. But I encourage you to keep an open dialogue with your personal physician as well. (They should also be able to keep you informed.)
In the meantime, you can find dozens of cancer-fighting techniques in my online learning program, my Essential Cancer Protocol. To learn more about this educational tool, or to enroll today, call 1-866-747-9421 and ask for order code EOV3Y700.
 “Could a Stool Test Help Spot Pancreatic Cancer?” U.S. News & World Report, 3/9/22. (https://www.usnews.com/news/health-news/articles/2022-03-09/could-a-stool-test-help-spot-pancreatic-cancer)
 “New blood test uses DNA ‘packaging’ patterns to detect multiple cancer types.” Science Daily, 5/29/19. (sciencedaily.com/releases/2019/05/190529131206.htm)
 “Vitamin D intake and the risk for pancreatic cancer in two cohort studies.” Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1688-95. doi: 10.1158/1055-9965.EPI-06-0206. PMID: 16985031.
 “Vitamin D May Lower Pancreatic Cancer Risk.” Health Day, 9/14/06. (consumer.healthday.com/cancer-information-5/pancreatic-cancer-news-105/vitamin-d-may-lower-pancreatic-cancer-risk-534925.html)
 “Gallstones Can Warn of Pancreatic Cancer Risk.” U.S. News & World Report, 5/13/22. (usnews.com/news/health-news/articles/2022-05-13/gallstones-can-warn-of-pancreatic-cancer-risk)